PTGS2 and lung carcinoma: The ability of COX-2 to promote escape from immunosurveillance is exemplified by the observation that inhibition of COX-2/PGE2 in mice with lung cancer reduces Treg-cell frequencies and increases the number of CXCR3+, anti-tumour effector T cells [24].